X
14Oct

[Ongoing Program] Life Sciences Dealmaking Symposium 2020 - Part 2 - October 27th, 12:00 pm - 1:00 pm EDT

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market. Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott's leading life sciences lawyers. Beginning October 20, we'll bring you a...
By: McDermott Will & Emery
Source Url: https://www.jdsupra.com/legalnews/ongoing-program-life-sciences-42712/

Related

Tracking the Latest in Employee Exemptions from the California Consumer Privacy Act

The California Consumer Privacy Act (“CCPA”) is set to take effect January 1, 2020. Since the anno...

Read More >

The SECURE Act doesn’t change one big problem for MEPs

While I loved the fact that pooled employer plan (PEP) is an option as a multiple employer plan (MEP...

Read More >

A New Landscape for Businesses with California Operations, Thanks to A.B.5

This month, Assembly Bill 5 (A.B. 5) was signed into California law. A.B. 5 codifies the “ABC Test”...

Read More >

Department of Justice, Federal Trade Commission Finalize New Vertical Merger Guidance

In a year of many firsts, the U.S. Department of Justice (DOJ) Antitrust Division and the Federal Tr...

Read More >

Delaware Supreme Court Upholds Unaffected Market Price in Statutory Appraisal Action

The Situation: Stockholders sought appraisal—judicial determination of the "fair value" of their st...

Read More >

PFI: benchmarking and market testing, a cause of conflict in the long run?

The ongoing Scottish case of Serco Limited v Forth Health Limited highlights the difficulties that c...

Read More >